3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
141
Lung Neoplasms
51
Pancreatic Neoplasms
30
Non-Squamous Non-Small Cell Lung Cancer
18
Neoplasms
15
Adenocarcinoma of Lung
14
Head and Neck Neoplasms
13
Glioblastoma
13
Gliosarcoma
12
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Carcinoma, Hepatocellular
9
Adenocarcinoma, Bronchiolo-Alveolar
9
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Squamous Cell
7
Carcinoma, Renal Cell
7
Astrocytoma
6
Oligodendroglioma
5
Carcinoma
5
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Glioma
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Interventions
Epoetin Alfa
7
Darbepoetin alfa
6
epoetin beta
4
Lenalidomide
4
Cyclophosphamide
4
ACE-011
4
fludarabine
3
Busulfan
3
thymoglobulin
2
telapristone acetate
2
luspatercept
2
fludarabine phosphate
2
Cyclosporine
2
Antilymphocyte Serum
2
AP 1903 reagent
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
vactosertib
1
ruxolitinib
1
roxadustat
1
obinutuzumab
1
ibrutinib
1
fosphenytoin
1
ferrous sulfate
1
ferric gluconate
1
ferric carboxymaltose
1
eltrombopag
1
angiotensin I (1-7)
1
Whole-Body Irradiation
1
Thiotepa
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia
×
Erlotinib Hydrochloride
×
Clear all
No trials found.